SHIONOGI's Company Policy is to strive “constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve.” Based on this, we are working on material issues (materiality) so that we will provide new value to customers and society through our business activities and thus attain growth and a sustainable society. SHIONOGI’s value creation process consists of continuously creating innovations that solve a wide range of healthcare issues while addressing the needs of patients and the world so that we can continue to grow sustainably with society, and share the fruits of these efforts with all our stakeholders. We aim to increase our business capital and maximize corporate value by continuously promoting this value creation process.
Value creation process